Lars Østergaard Pedersen

Author

Also Known As

L O Pedersen, L Østergaard Pedersen, L. Ø. PEDERSEN, L. Ø. Pedersen, L. Østergaard Pedersen, L.Ø. Pedersen, LARS ØSTERGAARD PEDERSEN, Lars O. Pedersen, Lars Ostergaard Pedersen, Lars Pedersen

Publications

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Lundbeck (Denmark)Danish Cancer Society University of Würzburg Frederiksberg Hospital

LØ

About

Lars Østergaard Pedersen is an author at University of Copenhagen specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2.5K
2	Natural Sciences	3	3	62
3	Social Sciences	3	3	145
4	Allergy	3	3	300
5	Health Sciences	1	1	20

Lars Østergaard Pedersen

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic Marcel Leist, Pietro Ghezzi, Giovanni Grasso, Science Certain Epo MutantsImmunologyBlood CellAre Tissue ProtectiveNeuroinflammation	2004	796
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity <i>in vivo</i> Serhat Erbayraktar, Giovanni Grasso, Alessandra Sfacteria, Proceedings of the National Academy of Sciences	2003	437
Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients. Mads Hald Andersen, Lars Østergaard Pedersen, Jürgen C. Becker, PubMed Elispot AnalysisApoptosisImmunologyImmunoeditingCell Death	2001	259
Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients. Mads Hald Andersen, Lars Østergaard Pedersen, B Capeller, PubMed ImmunologyAntigen ProcessingCd4 T Cell ResponsesCancer PatientsImmunotherapy	2001	255
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration Jae Kyu Ryu, Victoria A. Rafalski, Anke Meyer‐Franke, Nature Immunology InflammationNeurodegenerative DiseasesMedicineImmunologyFibrinolysis	2018	205
T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides. Svend Larsen, Lars Østergaard Pedersen, Søren Buus, The Journal of Experimental Medicine T Cell ResponsesAdaptive Immune SystemImmunologyImmunodominanceImmunologic Mechanism	1996	128
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin Kerstin Otto, Mads Hald Andersen, Andreas O. Eggert, Vaccine Tumor ImmunologyCancer ImmunosurveillanceMedicineT-regulatory CellImmunology	2004	111
Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial Hayk Davtyan, Anahit Ghochikyan, Irina Petrushina, Journal of Neuroscience Adaptive Immune SystemImmunologyImmune RegulationImmunodominanceEpitope Vaccine	2013	111
Establishment of a quantitative ELISA capable of determining peptide – MHC class I interaction Christina Sylvester‐Hvid, Nanna Ny Kristensen, Thomas Blicher, Tissue Antigens	2002	95
Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer’s Disease: A Translational Study of Neuropathological and Inflammatory Markers Trine Schütt, Lone Helboe, Lars Østergaard Pedersen, Journal of Alzheimer s Disease Geriatric PsychiatryNeuropsychologyAgingBrain DevelopmentPrefrontal Cortex	2016	91

Page 1